Mangiferin attenuates Th1/Th2 cytokine imbalance in an ovalbumin-induced asthmatic mouse model

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Guo, Hong Wei ^a,b,c   Yun, Chen Xia ^d   Hou, Guang Han ^c   Du, Jun ^c   Huang, Xin ^a,b   Lu, Yi ^a,b   Keller, Evan T ^e   Zhang, Jian ^a,b   Deng, Jia Gang ^c  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Guangxi Institute of Traditional Chinese Medicine   (China)

^d GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; DEXAMETHASONE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MANGIFERIN; PROSTAGLANDIN D2; RANTES; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MESSENGER RNA; OVALBUMIN; XANTHONE DERIVATIVE;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG STRUCTURE; EOSINOPHIL COUNT; FEMALE; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE; ANIMAL; ASTHMA; CHEMICALLY INDUCED; DISEASE MODEL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; PULMONARY EOSINOPHILIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

ANIMALS; ASTHMA; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; XANTHONES;

EID: 84903512586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100394     Document Type: Article

References (59)

1. Busse WW Jr, Lemanske RF (2001) Asthma. N Engl J Med 344: 350-362.
2. Hammad H, Lambrecht BN (2011) Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 66: 579-587.
3. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, et al. (1994) Cytokinei-nduced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180: 1961-1966. (Pubitemid 24328587)
4. Yuan Y, Yang B, Ye Z, Zhang M, Yang X, et al. (2013) Sceptridium ternatum extract exerts antiasthmatic effects by regulating Th1/Th2 balance and the expression levels of leukotriene receptors in a mouse asthma model. J Ethnopharmacol 149: 701-706.
5. Pernis AB, Rothman PB (2002) JAK-STAT signaling in asthma. J Clin Invest 109: 1279-1283. (Pubitemid 34546890)
6. Kaplan MH (2005) STAT4: a critical regulator of inflammation in vivo. Immunol Res 31: 231-242.
7. Li CC, Ye LP, Su MS, Li MR, Zhang HL, et al. (2007) [Effect of Radix Astragali on signal transducer and activator of transcription activator-4 and its mRNA expression in a rat model of asthma]. Zhonghua Er Ke Za Zhi 45: 727-731.
8. Li CC, Ye LP, Su MS, Hu XG, Zhang WX, et al. (2006) [Effect of achyranthes bidentata polysaccharides on signal transducer and activator of transcription 6 and its mRNA expression in a rat model of asthma]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 22: 210-214.
9. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
10. Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, et al. (2002) T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 3: 549-557. (Pubitemid 34662307)
11. Lee CC, Huang HY, Chiang BL (2008) Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 16: 60-65.
12. Hirahara K, Yamashita M, Iwamura C, Shinoda K, Hasegawa A, et al. (2008) Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness. J Allergy Clin Immunol 122: 512-520.
13. Ho IC, Glimcher LH (2002) Transcription: tantalizing times for T cells. Cell 109 Suppl: S109-S120.
14. Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK (2002) Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 176: 165-173. (Pubitemid 34692590)
15. Wang Q, Deng J, Yang K, Xu L (2011) [Effects of mangiferin on cytokines in rats with chronic bronchitis and expression of macrophage COX-2 in mice]. Zhongguo Zhong Yao Za Zhi 36: 1348-1352.
16. Garrido G, Gonzalez D, Delporte C, Backhouse N, Quintero G, et al. (2001) Analgesic and anti-inflammatory effects of Mangifera indica L. extract (Vimang). Phytother Res 15: 18-21. (Pubitemid 32155103)
17. Leiro J, Garcia D, Arranz JA, Delgado R, Sanmartin ML, et al. (2004) An Anacardiaceae preparation reduces the expression of inflammation-related genes in murine macrophages. Int Immunopharmacol 4: 991-1003. (Pubitemid 38844174)
18. Sanchez GM, Re L, Giuliani A, Nunez-Selles AJ, Davison GP, et al. (2000) Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 42: 565-573.
19. Prabhu S, Jainu M, Sabitha KE, Devi CS (2006) Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. J Ethnopharmacol 107: 126-133. (Pubitemid 44038820)
20. Garcia-Rivera D, Delgado R, Bougarne N, Haegeman G, Berghe WV (2011) Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells. Cancer Lett 305: 21-31.
21. Singh SK, Kumar Y, Kumar SS, Sharma VK, Dua K, et al. (2009) Antimicrobial evaluation of mangiferin analogues. Indian J Pharm Sci 71: 328-331.
22. Li X, Cui X, Sun X, Li X, Zhu Q, et al. (2010) Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res 24: 893-899.
23. Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J (2005) Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97: 497-501. (Pubitemid 40312325)
24. Das J, Ghosh J, Roy A, Sil PC (2012) Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/ nitrosative stress via Nrf2-NFkappaB pathways. Toxicol Appl Pharmacol 260: 35-47.
25. Prabhu S, Jainu M, Sabitha KE, Devi CS (2006) Cardioprotective effect of mangiferin on isoproterenol induced myocardial infarction in rats. Indian J Exp Biol 44: 209-215. (Pubitemid 43351244)
26. Prabhu S, Jainu M, Sabitha KE, Shyamala DC (2006) Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. Vascul Pharmacol 44: 519-525. (Pubitemid 43766674)
27. Jagetia GC, Baliga MS (2005) Radioprotection by mangiferin in DBAxC57BL mice: a preliminary study. Phytomedicine 12: 209-215. (Pubitemid 40348622)
28. Garcia D, Escalante M, Delgado R, Ubeira FM, Leiro J (2003) Anthelminthic and antiallergic activities of Mangifera indica L. stem bark components Vimang and mangiferin. Phytother Res 17: 1203-1208. (Pubitemid 38057180)
29. Wei Z, Yan L, Deng J, Deng J (2011) [Effects of mangiferin on MAPK signaling pathway in chronic inflammation]. Zhongguo Zhong Yao Za Zhi 36: 1798-1802.
30. Guha S, Ghosal S, Chattopadhyay U (1996) Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy 42: 443-451. (Pubitemid 26379933)
31. Makare N, Bodhankar S, Rangari V (2001) Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J Ethnopharmacol 78: 133-137. (Pubitemid 32994781)
32. Telang M, Dhulap S, Mandhare A, Hirwani R (2013) Therapeutic and cosmetic applications of mangiferin: a patent review. Expert Opin Ther Pat 23: 1561-1580.
33. Rivera DG, Hernandez I, Merino N, Luque Y, Alvarez A, et al. (2011) Mangifera indica L. extract (Vimang) and mangiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma. J Pharm Pharmacol 63: 1336-1345.
34. Ram A, Das M, Gangal SV, Ghosh B (2004) Para-Bromophenacyl bromide alleviates airway hyperresponsiveness and modulates cytokines, IgE and eosinophil levels in ovalbumin-sensitized and -challenged mice. Int Immunopharmacol 4: 1697-1707. (Pubitemid 39348866)
35. Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson JA (1995) Timecourse of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J 8: 2104-2113.
36. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, et al. (1994) Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 24: 73-80. (Pubitemid 24210819)
37. Kanda A (2009) What Is New About Eosinophil Activation in Asthma and Allergic Disease. In: Chihara J, edito: Springer. pp. 95-107.
38. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, et al. (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298-304.
39. Barnes PJ (2008) The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118: 3546-3556.
40. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, et al. (2011) Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127: 701-721.
41. Mukherjee AB, Zhang Z (2011) Allergic asthma: influence of genetic and environmental factors. J Biol Chem 286: 32883-32889.
42. Lee SY, Huang CK, Zhang TF, Schofield BH, Burks AW, et al. (2001) Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity. Clin Immunol 101: 220-228.
43. Yan L, Xiao-Ling S, Zheng-Yan C, Guo-Ping L, Sen Z, et al. (2013) HSP70/CD80 DNA vaccine inhibits airway remodeling by regulating the transcription factors T-bet and GATA-3 in a murine model of chronic asthma. Arch Med Sci 9: 906-915.
44. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, et al. (2002) Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 168: 443-449. (Pubitemid 34014147)
45. Peters-Golden M, Henderson WR Jr (2007) Leukotrienes. N Engl J Med 357: 1841-1854.
46. Coffey M, Peters-Golden M (2003) Extending the understanding of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 3: 57-63. (Pubitemid 36159350)
47. Barnes PJ (2008) The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118: 3546-3556.
48. Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP (2012) Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy 42: 712-737.
49. Li XM, Brown L (2009) Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol 123: 297-306, 307-308.
50. Shi YH, Shi GC, Wan HY, Jiang LH, Ai XY, et al. (2011) Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J (Engl) 124: 1951-1956.
51. Carneiro ER, Xavier RA, De Castro MA, Do NC, Silveira VL (2010) Electroacupuncture promotes a decrease in inflammatory response associated with Th1/Th2 cytokines, nitric oxide and leukotriene B4 modulation in experimental asthma. Cytokine 50: 335-340.
52. Lee CM, Jung ID, Noh KT, Lee JS, Park JW, et al. (2012) An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthma. PLoS One 7: e34554.
53. Kiwamoto T, Ishii Y, Morishima Y, Yoh K, Maeda A, et al. (2006) Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med 174: 142-151. (Pubitemid 44015387)
54. Chen W, Khurana HG (2007) Signal transducer and activator of transcription signals in allergic disease. J Allergy Clin Immunol 119: 529-541, 542-543.
55. Mowen KA, Glimcher LH (2004) Signaling pathways in Th2 development. Immunol Rev 202: 203-222. (Pubitemid 39576914)
56. Ouyang W, Lohning M, Gao Z, Assenmacher M, Ranganath S, et al. (2000) Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12: 27-37. (Pubitemid 30069212)
57. Chang HC, Han L, Goswami R, Nguyen ET, Pelloso D, et al. (2009) Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood 113: 5887-5890.
58. Lighvani AA, Frucht DM, Jankovic D, Yamane H, Aliberti J, et al. (2001) T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci U S A 98: 15137-15142. (Pubitemid 34013982)
59. Oh CK, Geba GP, Molfino N (2010) Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19: 46-54.